Considerations in the use of lipid-based drug products

J Intraven Nurs. 1998 Nov-Dec;21(6):326.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / chemistry
  • Doxorubicin / adverse effects*
  • Doxorubicin / chemistry
  • Drug Carriers
  • Extravasation of Diagnostic and Therapeutic Materials / etiology*
  • Extravasation of Diagnostic and Therapeutic Materials / pathology
  • Humans
  • Inflammation
  • Infusions, Intravenous
  • Liposomes
  • Necrosis

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Liposomes
  • Doxorubicin